Name | Y08284 |
---|
Description | Y08284 is a potent, selective, oral active CBP bromodomain inhibitor with an IC50 of 4.21 nM. Y08284 suppresses the proliferation of prostate cancer cell lines LNCaP, C4-2B, and 22Rv1. Antitumor activity[1]. |
---|---|
Related Catalog | |
In Vivo | Y08284 demonstrates favorable cell permeability and good pharmacokinetic properties, with oral bioavailability of 25.9%[1]. |
References |
Molecular Formula | C26H25FN4O4 |
---|---|
Molecular Weight | 476.50 |